The Effect of Dexmedetomidine in the Management of Pain After Uterine Artery Embolization

NACompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

September 30, 2012

Study Completion Date

September 30, 2012

Conditions
Pain Control
Interventions
DRUG

Dexmedetomidine

Dexmedetomidine(Dexmedetomidine 2 mL and normal saline 98 mL mixed -\> 2㎍/mL) : the infusion of 0.2㎍/kg/hr is started at 30 minutes before the procedure and the infusion dose is raised to 0.4㎍/kg/hr after completion of procedure

DRUG

Normal saline 0.9%

Normal saline 100mL(guess as 2㎍/mL):the infusion of 0.2㎍/kg/hr is started at 30 minutes before the procedure and the infusion dose is raised to 0.4㎍/kg/hr after completion of procedure

Trial Locations (1)

Unknown

Department of Anesthesiology and Pain Medicine and Anesthesia and Pain Research Institute, Yonsei University College of Medicine, Seoul

All Listed Sponsors
lead

Severance Hospital

OTHER

NCT01578174 - The Effect of Dexmedetomidine in the Management of Pain After Uterine Artery Embolization | Biotech Hunter | Biotech Hunter